Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction

Status:
Completed

Trial end date:
2006-09-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the dose of drug which is most effective in the delineation of dead heart muscle.

Phase 2

Bayer